Mechanisms of gastroprotective effect of eugenol in indomethacin-induced ulcer in rats

Phytotherapy Research

Volumn 22, Issue 10, 2008, Pages 1361-1366

  Morsy, Mohamed A ^a   Fouad, Amr A ^a  

^a Minia University   (Egypt)

Author keywords

Eugenol; Gastric ulcer; Glibenclamide; Indomethacin; Ruthenium red

Indexed keywords

EUGENOL; FREE RADICAL; GLIBENCLAMIDE; GLUTATHIONE; INDOMETACIN; MALONALDEHYDE; MUCIN; NITRITE; PEPSIN A; RUTHENIUM RED;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; MALE; NONHUMAN; PYLORUS LIGATION; RAT; SINGLE DRUG DOSE; STOMACH ACID SECRETION; STOMACH JUICE; STOMACH MUCOSA; STOMACH ULCER;

ANIMALS; EUGENOL; GASTRIC MUCOSA; GLYBURIDE; INDOMETHACIN; MALE; MALONDIALDEHYDE; NITRITES; RATS; RATS, SPRAGUE-DAWLEY; RUTHENIUM RED; STOMACH; STOMACH ULCER;

RATTUS;

EID: 55449117707     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2502     Document Type: Article

References (36)

1. Aihara E, Hayashi M, Sasaki Y, Kobata A, Takeuchi K. 2005. Mechanisms underlying capsaicin-stimulated secretion in the stomach: comparison with mucosal acidification. J Pharmacol Exp Ther 315: 423-432.
2. Alumets J, Ekelund M, Hakanson R, Hedenbro J, Rehfeld JF, Sundler F, Vallgren S. 1982. Gastric acid response to pylorus ligation in rats: is gastrin or histamine involved? J Physiol 323: 145-156.
3. Biswas K, Bandyopadhyay U, Chattopadhyay I, Varadaraj A, Ali E, Banerjee RK. 2003. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J Biol Chem 278: 10993-11001.
4. Bose M, Motghare VM, Dakhale GN, Turankar AV. 2003. Antiulcer activity of levcromakalim and nicorandil in albino rats: a comparative study. Pol J Pharmacol 55: 91-95.
5. Capasso R, Pinto L, Vuotto ML, Di Carlo G. 2000. Preventive effect of eugenol on PAF- and ethanol-induced gastric mucosal damage. Fitoterapia 71: S131-S137.
6. Fukushima K, Aoi Y, Kato S, Takeuchi K. 2006. Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins. World J Gastroenterol 12: 3031-3037.
7. Garcia Rodriguez LA, Barreales Tolosa L. 2007. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 132: 498-506.
8. Ghanam K, Ea-Kim L, Javellaud J, Oudart N. 2000. Involvement of potassium channels in the protective effect of 17beta-estradiol on hypercholesterolemic rabbit carotid artery. Atherosclerosis 152: 59-67.
9. Hara N, Hara Y, Natsume Y, Goto Y. 1991. Gastric hyperacidity and mucosal damage caused by hypothermia correlate with increased in GABA concentrations of the rat brain. Eur J Pharmacol 194: 77-81.
10. Horie S, Yamamoto H, Michael GJ, Uchida M, Belai A, Watanabe K, Priestley JV, Murayama T. 2004. Protective role of vanilloid receptor type 1 in HCl-induced gastric mucosal lesions in rats. Scand J Gastroenterol 39: 303-312.
11. Ito M, Murakami K, Yoshino M. 2005. Antioxidant action of eugenol compounds: role of metal ion in the inhibition of lipid peroxidation. Food Chem Toxicol 43: 461-466.
12. Kabuto H, Tada M, Kohno M. 2007. Eugenol [2-methoxy-4-(2-propenyl)phenol] prevents 6-hydroxydopamine-induced dopamine depression and lipid peroxidation inductivity in mouse striatum. Biol Pharm Bull 30: 423-427.
13. Khattab MM, Gad MZ, Abdallah D. 2001. Protective role of nitric oxide in indomethacin-induced gastric ulceration by a mechanism independent of gastric acid secretion. Pharmacol Res 43: 463-467.
14. Kim SS, Oh O-J, Min H-Y, Park E-J, Kim Y, Park HJ, Han YN, Lee SK. 2003. Eugenol suppresses cyclooxygenase-2 expression in lipopolysaccharide-stimulated mouse macrophage RAW264.7 cells. Life Sci 73: 337-348.
15. Kwiecien S, Brzozowski T, Konturek SJ. 2002. Effects of reactive oxygen species action on gastric mucosa in various models of mucosal injury. J Physiol Pharmacol 53: 39-50.
16. Li W, Tsubouchi R, Qiao S, Haneda M, Murakami K, Yoshino, M. 2006. Inhibitory action of eugenol compounds on the production of nitric oxide in RAW264.7 macrophages. Biomed Res 27: 69-74.
17. + channels-mediated vasodilatation. Vasc Pharmacol 38: 43-49.
18. Maia JL, Lima-Junior RCP, David JP, David JM, Santos FA, Rao VS. 2006. Oleanolic acid, a pentacyclic triterpene attenuates the mustard oil-induced colonic nociception in mice. Biol Pharm Bull 29: 82-85.
19. +2 and the calmodulin messenger system in pepsinogen secretion from isolated rabbit gastric mucosa. Gut 33: 21-25.
20. Moncada S, Bolanos JP. 2006. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97: 1676-1689.
21. Nangle MR, Gibson TM, Cotter MA, Cameron NE. 2006. Effects of eugenol on nerve and vascular dysfunction in streptozotocin-diabetic rats. Planta Med 72: 494-500.
22. Narita T, Okabe N, Hane M, Yamamoto Y, Tani K, Naito Y, Hara S. 2006. Nonsteroidal anti-inflammatory drugs induce hypermotilinemia and disturbance of interdigestive migrating contractions in instrumented dogs. J Vet Pharmacol Ther 29: 569-577.
23. Ogata M, Kaneya D, Shin-Ya K, Li L, Abe Y, Katoh H, Seki S, Seki Y, Gonda R, Urano S, Endo T. 2005. Trapping effect of eugenol on hydroxyl radicals induced by L-DOPA in vitro. Chem Pharm Bull 53: 1167-1170.
24. Patel HM, Santani DD, Goswami SG. 2001. Evaluation of the effects of nicorandil on experimentally induced gastric ulcers. Pharmacology 63: 154-159.
25. Peskar BM, Ehrlich K, Peskar BA. 2002. Role of ATP-sensitive potassium channels in prostaglandin-mediated gastroprotection in the rat. J Pharmacol Exp Ther 301: 969-974.
26. 4 in human PMNL cells. Prostaglandins, Leukot Essent Fatty Acids 74: 23-27.
27. Rossowski WJ, Jiang NY, Coy DH. 1997. Adrenomedullin, amylin, calcitonin gene-related peptide and their fragments are potent inhibitors of gastric acid secretion in rats. Eur J Pharmacol 336: 51-63.
28. Sanyal AK, Debnath PK, Bhattacharya SK, Gode KD. 1971. The effect of cyproheptadine on gastric activity. In Peptic ulcer, Pfeiffer CJ (ed.). Munksgaard: Copenhagen; 312-318.
29. Sastry KVH, Moudgal RP, Mohan J, Tyagi JS, Rao GS. 2002. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 306: 79-82.
30. Tashima K, Nakashima M, Kagawa S, Kato S, Takeuchi K. 2002. Gastric hyperemic response induced by acid back-diffusion in rat stomachs following barrier disruption - relation to vanilloid type-1 receptors. Med Sci Monit 8: BR157-163.
31. Tiku AB, Abraham SK, Kale RK. 2004. Eugenol as an in vivo radioprotective agent. J Radiat Res 45: 435-440.
32. Wallace JL, Bak A, McKnight W, Asfaha S, Sharkey KA, MacNaughton WK. 1998. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity. Gastroenterology 115: 101-109.
33. Winzler RJ. 1955. Determination of serum glycoproteins. Methods Biochem Anal 2: 279-311.
34. Yamamoto H, Horie S, Uchida M, Tsuchiya S, Murayama T, Watanabe K. 2001. Effects of vanilloid receptor agonists and antagonists on gastric antral ulcers in rats. Eur J Pharmacol 432: 203-210.
35. Yang BH, Piao ZG, Kim Y-B, Lee C-H, Lee JK, Park K, Kim JS, Oh SB. 2003. Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res 82: 781-785.
36. Yuan Y, Padol IT, Hunt RH. 2006. Peptic ulcer disease today. Nat Clin Pract Gastroenterol Hepatol 3: 80-89.